Short-Acting Insulin Market, By Drug (Novolog, Humalog and Humulin), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Short-Acting Insulin Market size was valued at USD 7,524.2 Million in 2023, expanding at a CAGR of 4.50% from 2024 to 2032.
The Short-Acting Insulin Market refers to the market segment dealing in insulin medications of a quick onset of action with a short, lengthier duration of effect. Short-acting insulin aims to provide glycemia control immediately post-meal to avoid glucose spikes due to food intake. Short-acting insulin is usually administered before or immediately after meals in order to closely mimic the body\'s natural supply of insulin to food intake. This is the very market of different pharmaceutical companies producing and distributing such medications to people with diabetes, so that these people may use them in a way of helping their body system regulate its blood sugar level effectively.
Short-Acting Insulin Market- Market Dynamics
Government policies at the federal, state, and municipal levels are critical to improving the quality and safety of healthcare. Changes in policy, systems, and the environment (PSE) are critical components of a long-term strategy to prevent chronic diseases. The goal of legislative regulations and environmental alterations is to make healthy behaviours more available or desirable while making detrimental exposures more difficult or illegal. Systemic interventions strive to improve an agency\'s or organization\'s operations and service delivery to the community. Diabetes is a chronic condition affecting over 30 million individuals. The Affordable Care Act of 2010 (ACA) established a shared responsibility paradigm among the government, employers, and individuals to ensure that everyone has unlimited access to affordable, high-quality health insurance in their local regions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as following:
GLOBAL SHORT-ACTING INSULIN MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Novo Nordisk AS
Sanofi
Eli Lilly and Company
Verily
Sensile
Others
GLOBAL SHORT-ACTING INSULIN MARKET, BY DRUG- MARKET ANALYSIS, 2019 - 2032
Novolog
Humalog
Humulin
GLOBAL SHORT-ACTING INSULIN MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
o The U.S.
o Canada
Europe
o Germany
o France
o Italy
o Spain
o United Kingdom
o Russia
o Netherlands
o Sweden
o Poland
o Rest of Europe
Asia Pacific
o India
o China
o South Korea
o Japan
o Australia
o Thailand
o Indonesia
o Philippines
o Rest of APAC
Latin America
o Brazil
o Mexico
o Argentina
o Colombia
o Rest of LATAM
The Middle East and Africa
o Saudi Arabia
o United Arab Emirates
o Israel
o Turkey
o Algeria
o Egypt
o Rest of MEA
TABLE OF CONTENT
1. Short-Acting Insulin Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Short-Acting Insulin Market Snippet by Drug
2.1.2. Short-Acting Insulin Market Snippet by Country
2.1.3. Short-Acting Insulin Market Snippet by Region
2.2. Competitive Insights
3. Short-Acting Insulin Key Market Trends
3.1. Short-Acting Insulin Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Short-Acting Insulin Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Short-Acting Insulin Market Opportunities
3.4. Short-Acting Insulin Market Future Trends
4. Short-Acting Insulin Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Short-Acting Insulin Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Short-Acting Insulin Market Landscape
6.1. Short-Acting Insulin Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Short-Acting Insulin Market – By Drug
7.1. Overview
7.1.1. Segment Share Analysis, By Drug, 2023 & 2032 (%)
7.1.2. Novolog
7.1.3. Humalog
7.1.4. Humulin
8. Short-Acting Insulin Market– By Geography
8.1. Introduction
8.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
8.2. North America
8.2.1. Overview
8.2.2. Short-Acting Insulin Key Manufacturers in North America
8.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.2.4. North America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.2.5. U.S.
8.2.5.1. Overview
8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.2.5.3. U.S. Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.2.6. Canada
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.2.6.3. Canada Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Short-Acting Insulin Key Manufacturers in Europe
8.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.3.4. Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.5. Germany
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.5.3. Germany Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.6. Italy
8.3.6.1. Overview
8.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.6.3. Italy Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.7. United Kingdom
8.3.7.1. Overview
8.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.7.3. United Kingdom Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.8. France
8.3.8.1. Overview
8.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.8.3. France Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.9. Russia
8.3.9.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.9.2. Russia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.10. Netherlands
8.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.10.2. Netherlands Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.11. Sweden
8.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.11.2. Sweden Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.12. Poland
8.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.12.2. Poland Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.3.13. Rest of Europe
8.3.13.1. Overview
8.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.3.13.3. Rest of the Europe Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Short-Acting Insulin Key Manufacturers in Asia Pacific
8.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.4.4. Asia Pacific Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.5. India
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.5.3. India Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.6. China
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.6.3. China Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.7. Japan
8.4.7.1. Overview
8.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.7.3. Japan Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.8. South Korea
8.4.8.1. Overview
8.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.8.3. South Korea Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.9. Australia
8.4.9.1. Overview
8.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.9.3. Australia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.10. Thailand
8.4.10.1. Overview
8.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.10.3. Thailand Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.11. Indonesia
8.4.11.1. Overview
8.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.11.3. Indonesia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.12. Philippines
8.4.12.1. Overview
8.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.12.3. Philippines Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.4.13. Rest of APAC
8.4.13.1. Overview
8.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.4.13.3. Rest of APAC Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5. Latin America
8.5.1. Overview
8.5.2. Short-Acting Insulin Key Manufacturers in Latin America
8.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.5.4. Latin America Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5.5. Brazil
8.5.5.1. Overview
8.5.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.5.3. Brazil Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5.6. Mexico
8.5.6.1. Overview
8.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.6.3. Mexico Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5.7. Argentina
8.5.7.1. Overview
8.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.7.3. Argentina Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5.8. Colombia
8.5.8.1. Overview
8.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.8.3. Colombia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.5.9. Rest of LATAM
8.5.9.1. Overview
8.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.5.9.3. Rest of LATAM Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6. Middle East and Africa
8.6.1. Overview
8.6.2. Short-Acting Insulin Key Manufacturers in Middle East and Africa
8.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
8.6.4. Middle East and Africa Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.5. Saudi Arabia
8.6.5.1. Overview
8.6.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.5.3. Saudi Arabia Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.6. United Arab Emirates
8.6.6.1. Overview
8.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.6.3. United Arab Emirates Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.7. Israel
8.6.7.1. Overview
8.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.7.3. Israel Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.8. Turkey
8.6.8.1. Overview
8.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.8.3. Turkey Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.9. Algeria
8.6.9.1. Overview
8.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.9.3. Algeria Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.10. Egypt
8.6.10.1. Overview
8.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.10.3. Egypt Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
8.6.11. Rest of MEA
8.6.11.1. Overview
8.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
8.6.11.3. Rest of MEA Market Size and Forecast, By Drug, 2019 - 2032 (US$ Million)
9. Key Vendor Analysis- Short-Acting Insulin Industry
9.1. Competitive Dashboard
9.2. Company Profiles
9.2.1. Novo Nordisk AS
9.2.2. Sanofi
9.2.3. Eli Lilly and Company
9.2.4. Verily
9.2.5. Sensile
9.2.6. Others
10. 360 Degree Analyst View
11. Appendix
11.1. Research Methodology
11.2. References
11.3. Abbreviations
11.4. Disclaimer
11.5. Contact Us
